Valérie Biousse

Featured in: Favicon

nature.com Favicon

wiley.com

jamanetwork.com Favicon

nejm.org

thelancet.com Favicon

aao.org

healio.com

Articles

PAMM and Retinal Fluid May Be Biomarkers for Anterior Ischemic Optic Neuropathy

Jan 15, 2025 | aao.org | Valérie Biousse

JAN 15, 2025 Neuro-Ophthalmology/Orbit In patients with anterior ischemic optic neuropathy (AION), quickly and effectively differentiating non-arteritic AION (NAION) from arteritic AION (AAION) can be a challenge. In this study, paracentral acute middle maculopathy (PAMM) and intraretinal/subretinal fluid on OCT appear to be distinguishing markers of the two conditions, although additional validation is necessary.
VIDEO: Nonmydriatic fundus OCT camera beneficial for emergency departments

Nov 7, 2024 | healio.com | Valérie Biousse |Anthony DeFino |Valerie Biousse MD |Eamon Dreisbach

You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].
Factors associated with vision loss in idiopathic intracranial hypertension patients with severe papilledema - Eye

Oct 30, 2024 | nature.com | Valérie Biousse

AbstractOur aim was to compare factors associated with poor versus good visual outcomes in idiopathic intracranial hypertension (IIH) patients with severe papilledema at initial presentation.
Updated CDC Guidelines for Syphilis Testing Promote Serology as the Mainstay

Sep 2, 2024 | aao.org | Valérie Biousse

With a continued surge in reported cases of syphilis in the United States over the past several years, it is not surprising that manifestations of ocular syphilis have also increased. In February 2024, the CDC provided this update on the best strategies for confirming or ruling out syphilis after conducting a large-scale systematic review of available literature.
Semaglutide May Be Associated With an Increased Risk of Developing NAION

Jul 29, 2024 | aao.org | Valérie Biousse

Semaglutide is a glucagon-like peptide-1 receptor agonist (GLP-1 RA) prescribed to assist with weight management in patients with type 2 diabetes (T2D) or those who are overweight/obese, and there have been anecdotal reports of nonarteritic anterior ischemic optic neuropathy (NAION) in patients taking this medication.
A Rise in Idiopathic Intracranial Hypertension Appears to Mirror Obesity Trends

Apr 5, 2024 | aao.org | Valérie Biousse

Idiopathic intracranial hypertension (IIH), a rare but serious vision-threatening disease, is on the rise in the United States according to a retrospective analysis of data from more than 85 million patients in a large US claims database, particularly among women aged 11–17 years and those of certain racial or ethnic minority groups.
An OCT-Based Remote Diagnosis Protocol May Help Emergency Physicians Identify CRAO

Mar 18, 2024 | aao.org | Valérie Biousse

Central retinal artery occlusion (CRAO) is considered a medical emergency, and rapid diagnosis and treatment are key to maximizing positive outcomes. A retrospective review of data from a pilot program in the United States suggests that a remote diagnosis approach may facilitate triage and treatment of patients with possible CRAO in the emergency department, improving clinical outcomes.
Neuro-Ophthalmology Consultations

Mar 14, 2024 | aao.org | Andrew Carey |Valérie Biousse

Neuro-ophthalmology consultations are critical to the diagnosis and management in the hospital setting. Prompt consultation prevents diagnostic errors and improves patient outcomes. The scarcity of neuro-ophthalmologists means that the increasing outpatient demand cannot be met, prompting many emergency department referrals by non–neuro-ophthalmologists.